PHF14 and pancreatic adenocarcinoma: Notably, all types of PHF14 gene alterations (∼2% frequency) in LIHC patients were “mutation.” Moreover, all alterations of PHF14 gene in UCS, TGCT, THYM, KIRP, PCPG and PAAD patients were “amplification,” with this being the predominant type of genetic alteration in all TCGA tumor samples.